What is the most important information I should know about TYMLOS? TYMLOS may cause serious side effects including: Possible bone cancer (osteosarcoma). During animal drug testing, TYMLOS caused some rats to develop a bone cancer called osteosarcoma.

What is the most important information I should know about TYMLOS? TYMLOS may cause serious side effects including: Possible bone cancer (osteosarcoma). During animal drug testing, TYMLOS caused some rats to develop a bone cancer called osteosarcoma.

IMPORTANT SAFETY INFORMATION . Contraindications: TYMLOS is contraindicated in patients with a history of systemic hypersensitivity to abaloparatide or to any component of the product formulation. Reactions have included anaphylaxis, dyspnea, and urticaria. Risk of Osteosarcoma: It is unknown whether TYMLOS will cause osteosarcoma in humans. . Osteosarcoma has been reported in patients treated ...

Open-label study evaluating the effects of TYMLOS on indices of bone formation. 2 Study design: Open-label, single-arm study that evaluated the effects of TYMLOS on indices of bone formation using transiliac bone biopsies in postmenopausal women with osteoporosis. 23 biopsies were included in the safety population; 19 biopsies were evaluable. Subjects received double fluorochrome labels before ...

IMPORTANT SAFETY INFORMATION. Contraindications: TYMLOS is contraindicated in patients with a history of systemic hypersensitivity to abaloparatide or to any component of the product formulation. Reactions have included anaphylaxis, dyspnea, and urticaria. Risk of Osteosarcoma: It is unknown whether TYMLOS will cause osteosarcoma in humans. Osteosarcoma has been reported in patients treated ...

What is the most important information I should know about TYMLOS? TYMLOS may cause serious side effects including: Possible bone cancer (osteosarcoma). During animal drug testing, TYMLOS caused some rats to develop a bone cancer called osteosarcoma.

(opens in a new tab) Radius Assist is an assistance program that may help those who cannot afford their medication; It provides TYMLOS (abaloparatide) injection therapy at no cost to qualified patients in need; To qualify, patients must meet the eligibility criteria and, along with their healthcare provider, submit all required documentation

For men and postmenopausal women with osteoporosis at high risk for fracture. Here’s where you can start the process to receive the support that best fits your needs.

The safety profile of TYMLOS has been well established in clinical trials and is similar in both postmenopausal women and men. Explore the most common side effects.

8 9 TREATMENT WITH TYMLOS Before first use, store your TYMLOS in the refrigerator, between 36 ºF and 46 ºF (2 ºC and 8 ºC). After first use, store TYMLOS for up to 30 days at room temperature, between